COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,740 Articles (22,502 medRxiv, 8,238 bioRxiv)

Most recent first Previous |  Page 2667: Articles 26661-26670  | Next

Standardization of enzyme-linked immunosorbent assays for serosurveys of the SARS-CoV-2 pandemic using clinical and at-home blood sampling
Klumpp-Thomas, C., Kalish, H., Drew, M., Hunsberger, S., Snead, K., Fay, M. P., Mehalko, J., Shunmugavel, A., Wall, V., Frank, P., Denson, J.-P., Hong, M., Gulten, G., Messing, S., Hicks, J., Michael, S., Gilette, W., Hall, M. D., Memoli, M., Esposito, D., Sadtler, K.
10.1101/2020.05.21.20109280 — Posted: 2020-05-25
SARS-CoV-2 seroprevalence and neutralizing activity in donor and patient blood from the San Francisco Bay Area
Ng, D., Goldgof, G., Shy, B., Levine, A., Balcerek, J., Bapat, S. P., Prostko, J., Rodgers, M., Coller, K., Pearce, S., Franz, S., Du, L., Stone, M., Pillai, S., Sotomayor-Gonzalez, A., Servellita, V., Sanchez-San Martin, C., Granados, A., Glasner, D. R., Han, L. M., Truong, K., Akagi, N., Nguyen, D. N., Neumann, N., Qazi, D., Hsu, E., Gu, W., Santos, Y. A., Custer, B., Green, V., Williamson, P., Hills, N. K., Lu, C. M., Whitman, J. D., Stramer, S., Wang, C., Reyes, K., Hakim, J., Sujishi, K., Alazzeh, F., Pharm, L., Oon, C.-Y., Miller, S., Kurtz, T., Hackett, J., Simmons, G., Busch, M. P., Chiu, C. Y.
10.1101/2020.05.19.20107482 — Posted: 2020-05-25
Can a herd immunity strategy become a viable option against COVID-19? A model-based analysis on social acceptability and feasibility
Akamatsu, T., Nagae, T., Osawa, M., Satsukawa, K., Sakai, T., Mizutani, D.
10.1101/2020.05.19.20107524 — Posted: 2020-05-25
SARS-CoV-2 epitopes are recognized by a public and diverse repertoire of human T-cell receptors
Shomuradova, A. S., Vagida, M. S., Sheetikov, S. A., Zornikova, K. V., Kiryukhin, D., Titov, A., Peshkova, I. O., Khmelevskaya, A., Dianov, D. V., Malasheva, M., Shmelev, A., Serdyuk, Y., Bagaev, D. V., Pivnyuk, A., Shcherbinin, D. S., Maleeva, A. V., Shakirova, N. T., Pilunov, A., Malko, D. B., Khamaganova, E. G., Biderman, B., Ivanov, A. V., Shugay, M., Efimov, G. A.
10.1101/2020.05.20.20107813 — Posted: 2020-05-25 Discussion: Onsite | Offsite
Immunochromatographic test for the detection of SARS-CoV-2 in saliva
Kashiwagi, K., Ishii, Y., Aoki, K., Yagi, S., Maeda, T., Miyazaki, T., Yoshizawa, S., Aoyagi, K., Tateda, K.
10.1101/2020.05.20.20107631 — Posted: 2020-05-25
A pattern categorization of CT findings to predict outcome of COVID-19 pneumonia
Jin, C., Wang, Y., Wu, C. C., Zhao, H., Liang, T., Liu, Z., Jian, Z., Li, R., Wang, Z., Li, F., Zhou, J., Cai, S., Liu, Y., Li, H., Li, Z., Liang, Y., Zhou, H., Wang, X., Ren, Z., Yang, J.
10.1101/2020.05.19.20107409 — Posted: 2020-05-25
Modelling information-dependent social behaviors in response to lockdowns: the case of COVID-19 epidemic in Italy
Buonomo, B., Della Marca, R.
10.1101/2020.05.20.20107573 — Posted: 2020-05-25 Discussion: Onsite
A Modelling Analysis of Strategies for Relaxing COVID-19 Social Distancing
Milne, G. J., Xie, S., Poklepovich, D.
10.1101/2020.05.19.20107425 — Posted: 2020-05-25
Diligent medical activities of a publicly designated medical institution for infectious diseases pave the way for overcoming COVID-19: A positive message to people working at the cutting edge
Nagano, T., Arii, J., Nishimura, M., Yoshida, N., Iida, K., Nishimura, Y., Mori, Y.
10.1101/2020.05.19.20107490 — Posted: 2020-05-25 Discussion: Onsite
Management of mild COVID-19: Policy implications of initial experience in India
Kumar, R., bhattacharya, b., Meena, V. P., Aggarwal, A., Tripathi, M., Soneja, M., Mittal, A., Singh, K., Gupta, N., Garg, R. K., Ratre, B., Kumar, B., Bhopale, S., Tiwari, P., Verma, A., Bhatnagar, S., Mohan, A., Wig, N., Guleria, R.
10.1101/2020.05.20.20107664 — Posted: 2020-05-25

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).